Exclusive: EssilorLuxottica's €7.2 billion euro Dutch deal faces EU probe – sources

By Foo Yun Chee

BRUSSELS (Reuters) – EssilorLuxottica’s (PA:) 7.2 billion euro ($8 billion) bid for Dutch opticians group GrandVision (AS:) will face a full-scale EU antitrust investigation after the company declined to offer concessions during an initial review, people familiar with the matter said on Friday.

EssilorLuxottica, which was formed last year from the merger of French lens maker Essilor and Italian eyewear group Luxottica, gave up the chance to offer concessions on Thursday, the deadline for doing so, the European Commission website showed.

Last year’s deal also triggered an investigation and feedback from nearly 4,000 opticians but was eventually cleared unconditionally.

The Commission, which will open the full-scale probe following the end of its preliminary review on Feb. 6, declined to comment.

Both EssilorLuxottica and GrandVision were not immediately available for comment. The sources said retailers and rival lens makers had expressed concerns to the EU competition watchdog. EssilorLuxottica however has pointed to the growing market clout of independent and specialist lens makers.

GrandVision, whose chains include Vision Express in Britain and For Eyes in the United States, would give EssilorLuxottica control of more than 7,000 outlets across the world where it already sells brands including Varilux lenses and Ray-Ban sunglasses.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.